| Fund ID | 805-6537275254 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 29% |
| Owned by non-U.S. persons | 19% |
| Fund | Type | Gross assets |
|---|---|---|
| New Leaf Biopharma Opportunities II, L.P. | Venture Capital | $131.9M |
| New Leaf Ventures IV, L.P. | Venture Capital | $118.9M |
| Nlv-Ii Spv-1, L.P. | Venture Capital | $77M |
New Leaf Ventures III, L.P. reports $100.5 million in gross assets, among the top 42% of private funds by size.
New Leaf Ventures III, L.P. is managed by New Leaf Venture Partners LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.